Zambia Medicines Regulatory Authority: Recall of CombiArt Tablets Batch 5813323A

• The Zambia Medicines Regulatory Authority has recalled CombiArt artemether/lumefantrine tablets, batch number 5813323A.
• The affected products were manufactured by Universal Corporation Ltd. in Kenya and distributed to various outlets in Zambia.
• The recall is due to concerns over the safety of the tablets.
• Universal Corporation Ltd. is responsible for ensuring compliance with local regulations regarding product recalls.

The ZAMRA has instructed all stakeholders to immediately stop the sale and distribution of the recalled products.

The Zambia Medicines Regulatory Authority (ZAMRA) has issued a recall notice for CombiArt artemether/lumefantrine tablets, batch number 5813323A. The affected products were manufactured by Universal Corporation Ltd. in Kenya and distributed to various outlets in Zambia. According to the ZAMRA, the recall is due to concerns over the safety of the tablets. The authority has instructed all stakeholders to immediately stop the sale and distribution of the recalled products.

The recall notice issued by the ZAMRA is in line with the country's regulatory framework for pharmaceuticals. Under the Medicines and Allied Substances Act No. 3 of 2013, the authority has the power to regulate the importation, sale, and distribution of medicines in Zambia. The act also provides for the recall of products that pose a risk to public health. Universal Corporation Ltd., as the manufacturer, is responsible for ensuring compliance with local regulations regarding product recalls.

The recall of CombiArt tablets in Zambia highlights the importance of effective supply chain management and regulatory compliance in the pharmaceutical industry. Lawyers advising clients on supply chain management should be aware of potential disruptions caused by product recalls and ensure that their clients are compliant with local regulations. The incident also underscores the need for manufacturers to prioritize quality control measures to prevent such incidents from occurring in the future.

Lawyers advising clients on supply chain management should watch for potential disruptions due to the recall of CombiArt tablets in Zambia, and ensure compliance with local regulations regarding product recalls.

Source: Original reporting via regulatory authority sources